Weekly Market Pulse: Are Higher Interest Rates Good For The Economy?

Interest rates surged last week on the back of a hotter-than-expected inflation report. The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400.

Equity Market Outlook Q2 2024: Extreme Distortions Everywhere - A Moment For Active Management

Home Market Outlook Today's Equity Market Outlook Q2 2024: Extreme Distortions Everywhere - A Moment For Active Management. Neuberger Berman: U.S. Economic growth has remained resilient and leads the world. Global Industrial Activity Is Picking Up While Early Signs Of Moderating Growth in Europe. We believe extreme market consensus presents a moment for active management.

Weekly Report: what happened at BBH last week (0408-0412)?

Should You Invest in the VanEck Biotech ETF (BBH)?

Weekly Report: what happened at BBH last week (0401-0405)?

Weekly Report: what happened at BBH last week (0325-0329)?

Weekly Report: what happened at BBH last week (0318-0322)?

Taking Stock: Q2 2024 Equity Market Outlook

Why Stocks Can Survive Bond Market Bumps

Weekly Report: what happened at BBH last week (0311-0315)?

2024 Outlook: A New 'Super Boom'? Or Chop And Churn?

Weekly Report: what happened at BBH last week (0304-0308)?

Why Biotech Stocks May Be Ready For A Recovery

Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.

Top 10 best performing biotech stocks of 2024 so far

The biotech sector is +13.6% in 2024. Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors and computer peripherals industries. Top 10 best performing biotech stocks of 2024 so far are Elevation Oncology and Janux.

Weekly Report: what happened at BBH last week (0226-0301)?

Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?

Weekly Report: what happened at BBH last week (0219-0223)?

Sector Insights: What Could Go Right In 2024?

Weekly Report: what happened at BBH last week (0212-0216)?

Where Are Biotech ETFs Headed After Q4 Earnings?